Evidence map›Paper›PMID 32117136›Full record

ArticleFrontiers in microbiology2020

Antibacterial Efficacy of Two Commercially Available Bacteriophage Formulations, Staphylococcal Bacteriophage and PYO Bacteriophage, Against Methicillin-Resistant

Tamta Tkhilaishvili, Lei Wang, Arianna Tavanti, Andrej Trampuz, Mariagrazia Di Luca

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Antibacterial Efficacy ofPathogens (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Broad-spectrum phage cocktail targetingFrontiers in microbiology · 2026
    Article
  6. Journal of clinical microbiology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. StudiesAntimicrobial agents and chemotherapy · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Is Galleria mellonella model a good alternative to study virulence in Staphylococcus aureus from bovine mastitis?Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Tamta TkhilaishviliCenter for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, Berlin Institute of Health, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Lei WangCenter for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, Berlin Institute of Health, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Arianna TavantiDepartment of Biology, University of Pisa, Pisa, Italy.
Andrej TrampuzCenter for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, Berlin Institute of Health, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Mariagrazia Di LucaCenter for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, Berlin Institute of Health, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEUniversity of Pisa · ITFreie Universität Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sessile bacteria growing on surfaces are more resistant to standard antibiotics than their planktonic counterpart. Due to their antimicrobial properties, bacteriophages have re-emerged as a promising approach to treat bacterial biofilm-associated infections. Here, we evaluated the ability of two commercially available phage formulations, Staphylococcal bacteriophage (containing the monophage Sb-1) and PYO bacteriophage (a polyphage), in preventing and eradicating an

Indexed as

antimicrobial activitybacteriophagesbiofilm-associated infectionconfocal laser scanning microscopyGalleria mellonellaisothermal microcalorimetrymethicillin-resistant Staphylococcus aureusphage therapy

Identifiers

PMID32117136
PMCPMC7018685
OpenAlexW3005300160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.